Earnings Feed
Start Free
Home/Filings/4/0001437749-24-014187
4//SEC Filing

LAROCHE RICHARD F JR 4

Accession 0001437749-24-014187

CIK 0001047335other
View on SEC.govCompany Profile

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 4:40 PM ET

Size

19.7 KB

Accession

0001437749-24-014187

Insider Transaction Report

Form 4
Period: 2024-04-30
NATIONAL HEALTHCARE CORPNHC
LAROCHE RICHARD F JR
Director
Transactions
  • Exercise/Conversion

    Option to Purchase Common Stock [2019 Grant]

    2024-04-30−4,000→ 3,500 total
    Exercise: $77.92From: 2019-05-09Exp: 2024-05-08→ Common Stock (7,500 underlying)
  • Exercise/Conversion

    Option to Purchase Common Stock [2019 Grant]

    2024-04-30−3,500→ 0 total
    Exercise: $77.92From: 2019-05-09Exp: 2024-05-08→ Common Stock (3,500 underlying)
  • Exercise/Conversion

    Common Stock (held in my name or my wife's name)

    2024-04-30$77.92/sh+4,000$311,680→ 0 total
  • Exercise/Conversion

    Common Stock (held in my name or my wife's name)

    2024-04-30$77.92/sh+3,500$272,720→ 0 total
  • Tax Payment

    Common Stock (held in my name or my wife's name)

    2024-04-30$90.87/sh−3,001$272,701→ 200,912 total
Holdings

  • Common Stock (ROTH IRA)

    114.833

  • Common Stock - Fam. Partnership (LR Ent.)

    28,000

  • Common Stock - Fam. Partnership (LFLP)

    (indirect: GP)
    96,000

  • Common Stock - Family LP (BFLP)

    (indirect: GP)
    30,000

  • Option to Purchase Common Stock [2020 Grant]

    Exercise: $64.64From: 2021-05-07Exp: 2025-05-06→ Common Stock (5,000 underlying)
    5,000

  • Option to Purchase Common Stock [2021 Grant]

    Exercise: $71.64From: 2022-05-06Exp: 2023-05-05→ Common Stock (7,500 underlying)
    7,500

  • Option to Purchase Common Stock [2023 Grant]

    Exercise: $55.75From: 2024-05-04Exp: 2028-05-03→ Common Stock (7,500 underlying)
    7,500

  • Option to Purchase Common Stock [2022 Grant]

    Exercise: $69.19From: 2023-05-05Exp: 2024-05-04→ Common Stock (7,500 underlying)
    7,500
Footnotes (4)
  • [F1]These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
  • [F2]Transaction totaled on the line below for securities of this title.
  • [F3]Shares were withheld by the Company to pay the exercise price.
  • [F4]Total amount for this title following transactions reported on this form.

Documents

1 file

Issuer

NATIONAL HEALTHCARE CORP

CIK 0001047335

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001012859

Filing Metadata

Form type
4
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 4:40 PM ET
Size
19.7 KB
View on SEC.gov